Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi to ax 466 jobs, step up focus on cancer, gene therapy R&D
Fierce Biotech
Thu, 06/20/19 - 09:56 am
Tags:
Sanofi, layoffs, Germany, France, R&D, immuno-oncology, gene therapy
Amphastar squeezes partners Momenta, Sandoz for $60M in Lovenox settlement
Fierce Pharma
Wed, 06/19/19 - 10:57 pm
Tags:
Sanofi, bloodthinners, Lovenox, generics, Amphastar, Momenta, Sandoz
Sanofi and Google join forces to create ‘Innovation Lab’
Pharmaforum
Tue, 06/18/19 - 09:57 am
Tags:
Sanofi, Google, innovation
Sanofi's Soliqua Edges Out Competitors in Blood Sugar Control Trial
Biopharma Dive
Mon, 06/10/19 - 07:34 pm
Tags:
Sanofi, diabetes, ADA, Soliqua, clinical trials
Will The Introduction Of A Third Potent Cholesterol Lowering Drug Expand or Shrink The Market?
Forbes
Mon, 06/10/19 - 10:31 am
Tags:
The Medicines Company, Amgen, Sanofi, Regeneron, inclisiran, PCSK9 inhibitors
Sanofi's Leadership Transition: What You Need To Know
Yahoo/Benzinga
Sun, 06/9/19 - 01:16 pm
Tags:
Sanofi, Pharma CEOs, Paul Hudson, Olivier Brandicourt
A struggling Sanofi is preparing to hire Novartis senior pharma exec Paul Hudson as new CEO, replacing Brandicourt -- report
Endpoints
Thu, 06/6/19 - 11:08 pm
Tags:
Sanofi, Pharma CEOs, Novartis, Paul Hudson, Olivier Brandicourt
Eli Lilly, BMS among 77 drugmakers targeted in Chinese financial probe
Fierce Pharma
Wed, 06/5/19 - 12:03 am
Tags:
China, Sanofi, Eli Lilly, Bristol-Myers Squibb
#ASCO19: Sanofi sets the stage for a late arrival of their multiple myeloma drug isatuximab — with J&J and Genmab laying in wait
Endpoints
Sun, 06/2/19 - 01:18 pm
Tags:
Sanofi, Multiple Myeloma, isatuximab, ASCO 2019
Mark Your Calendar For These June PDUFA Dates
Yahoo/Benzinga
Sat, 06/1/19 - 12:52 pm
Tags:
FDA, Merck, Zerbaxa, XERIS, Gvoke HypoPen, Keytruda, Amag Pharmaceuticals, Palatin, Vyleesi, Acer Therapeutics, Edsivo, Sanofi, Regeneron, Dupixent, Alexion, Soliris, Retrophin, Thiola, Allergan, Botox
Go or no go? Merck, Regeneron and Alexion await US expansion
EP Vantage
Thu, 05/30/19 - 09:39 am
Tags:
Merck, Keytruda, Sanofi, Regeneron, Dupixent, Alexion, Soliris, FDA, Dova Pharmaceuticals, Retrophin
Verily lures major pharmas with promise of speedier clinical research
BioPharma Dive
Tue, 05/21/19 - 11:07 pm
Tags:
Verily, Alphabet, clinical trials, Pfizer, Novartis, Sanofi, Otsuka
Sanofi Joins Drugmakers' Bid to Treat Patients With Software
Yahoo/Bloomberg
Wed, 05/15/19 - 10:26 am
Tags:
Sanofi, digital pharma, Happify Health, digital therapeutics, depression, multiple sclerosis
Vendu! Weeks after Sanofi cuts ties to Alnylam, the pharma giant offloads $842M of its stock
Endpoints
Fri, 05/3/19 - 10:52 pm
Tags:
Sanofi, Alnylam
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 04/28/19 - 10:00 pm
Tags:
Regeneron, Sanofi, Praluent, FDA, Heron Therapeutics, HTX-011, Nabiva, Orchard Therapeutics, Akari Therapeutics, Aldeyra Therapeutics, BioTime, Audentes Therapeutics, Adaptimmune, GW Pharma, Ionis, Biogen, Ovid Therapeutics, TransMedics, IPOs, Trevi Therapeutics
Praluent's lower list price isn't yielding better sales yet
Biopharma Dive
Sun, 04/28/19 - 12:36 pm
Tags:
Sanofi, Regeneron, Praluent, drug pricing
U.S. FDA approves expanded label for Regeneron/Sanofi's cholesterol drug
Yahoo/Reuters
Sat, 04/27/19 - 10:20 am
Tags:
Regeneron, Sanofi, Praluent, MACE, FDA
Sanofi's Eloctate, a Bioverativ buyout centerpiece, suffers on Roche's Hemlibra launch
Fierce Pharma
Fri, 04/26/19 - 07:39 pm
Tags:
Sanofi, Bioverativ, M&A, diabetes, Eloctate, Roche, Hemlibra
Sanofi (SNY) Q1 Earnings Top, Genzyme & Vaccines Drive Sales
Yahoo/Zacks.com
Fri, 04/26/19 - 10:36 am
Tags:
Sanofi, earnings
Sanofi leases its soon-to-be-former Genzyme HQ to Bluebird Bio—at a profit
Fierce Pharma
Tue, 04/23/19 - 11:05 pm
Tags:
Sanofi, Bluebird Bio, Kendall Square, Boston

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.